![PSA Screening for Aggressive Prostate Cancer Supported in Men With Lynch Syndrome–Associated Pathogenic Variants PSA Screening for Aggressive Prostate Cancer Supported in Men With Lynch Syndrome–Associated Pathogenic Variants](https://cdn.sanity.io/images/0vv8moc6/onclive/4d55153a4787e65c65beb587468049c237a9d280-200x275.jpg)
PSA Screening for Aggressive Prostate Cancer Supported in Men With Lynch Syndrome–Associated Pathogenic Variants
![Marielle NOBBENHUIS - Consultant - The Royal Marsden NHS Foundation Trust, London - Department of Gynaecological Oncology Marielle NOBBENHUIS - Consultant - The Royal Marsden NHS Foundation Trust, London - Department of Gynaecological Oncology](https://i1.rgstatic.net/ii/profile.image/318103085355009-1452853093860_Q512/Marielle-Nobbenhuis.jpg)
Marielle NOBBENHUIS - Consultant - The Royal Marsden NHS Foundation Trust, London - Department of Gynaecological Oncology
![Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial - The Lancet Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial - The Lancet](https://www.thelancet.com/cms/attachment/2001928947/2006666917/gr1.gif)
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial - The Lancet
![NIHR BRC at The Royal Marsden and the ICR on Twitter: "Professor Ros Eeles leads our Prostate Cancer research theme - find out more about her research into genetics, and how it NIHR BRC at The Royal Marsden and the ICR on Twitter: "Professor Ros Eeles leads our Prostate Cancer research theme - find out more about her research into genetics, and how it](https://pbs.twimg.com/media/ESl6Ce3XgAIDMh4.jpg)